News

Evoq Remedies Limited informed the BSE Limited that the trading window for purchasing, selling, or dealing in the company`s equity shares will be closed for directors, promoters, designated persons, and insiders from Thursday, October 1, 2026, until 48 hours after the declaration and publication of the unaudited financial results for the half-year ended September 30, 2026.

Evoq Remedies will hold a meeting of the Board of Directors of the Company on 30 May 2026.

Evoq Remedies has revised the meeting of the Board of Directors which was scheduled to be held on 14 May 2026. The meeting will now be held on 27 May 2026.

Evoq Remedies will hold a meeting of the Board of Directors of the Company on 14 May 2026.

Evoq Remedies has revised the meeting of the Board of Directors which was scheduled to be held on 9 October 2025. The meeting will now be held on 10 October 2025.Powered by Capital Market - Live News